XBP1 and triple-negative breast carcinoma: Previous research has proved that UPR-related IRE1/XBP1 signaling pathway plays a role in tumor progression, with high expression of XBP1s protein correlating with poor prognosis in glioblastoma, triple-negative breast cancer, and pre-B acute lymphoblastic leukemia [27–29].